e-learning
resources
Vienna 2009
Monday, 14.09.2009
Animal models of airways inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of a thrombin inhibitor on murine bronchial asthma
A. Fujiwara, M. Naito, T. Takagi, A. Ebihara, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, Y. Takei, O. Taguchi (Tsu-city, Japan)
Source:
Annual Congress 2009 - Animal models of airways inflammation
Session:
Animal models of airways inflammation
Session type:
Thematic Poster Session
Number:
2106
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Fujiwara, M. Naito, T. Takagi, A. Ebihara, T. Kobayashi, H. Kobayashi, C. D‘Alessandro-Gabazza, E. Gabazza, Y. Takei, O. Taguchi (Tsu-city, Japan). Effect of a thrombin inhibitor on murine bronchial asthma. Eur Respir J 2009; 34: Suppl. 53, 2106
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Effect of thrombin inhalation in a murine model of bronchial asthma
Source: Annual Congress 2011 - Experimental modulation of airway inflammation
Year: 2011
Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Effect of a pan-JAK inhibitor pyridone 6 on airway responses in murine asthma model
Source: Annual Congress 2010 - Asthma: basic science and clinical studies
Year: 2010
Role of thrombin-activatable fibrinolysis inhibitor in bronchial asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Role of thrombin and thrombin receptor in the activation of human bronchial epithelial cells during airway inflammation
Source: Eur Respir J 2007; 30: Suppl. 51, 523s
Year: 2007
Effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic inflammation in guinea pigs
Source: Eur Respir J 2003; 22: Suppl. 45, 106s
Year: 2003
Effects of a selective phosphodiesterase IV and V inhibitor in a murine model of chronic asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 128s
Year: 2004
Effect of a neutrophil elastase inhibitor on airway goblet cell secretion in sensitized guinea pigs
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001
Protective effect of thrombomodulin in a murine model of allergen-induced asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
The PAR
2
-activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma
Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology
Year: 2004
Activated protein C inhibits bronchial inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 618s
Year: 2002
Influence of acid sphingomyelinase deficiency in a murine model of allergen-induced asthma
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Effect of anti-IL17 and/or Rho-kinase inhibitor treatments on vascular remodelling in an asthma model in mice
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Role of of symbicort in treatment of bronchial asthma
Source: Annual Congress 2010 - Treatment options for asthma
Year: 2010
Influence of endogenous corticosteroids on bronchial protective properties of β
2
-agonist in patients with bronchial asthma with cold bronchial hyperresponsiveness
Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators
Year: 2010
Role of mouse mast cell protease 4 in a murine model of allergic asthma
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Effect of verapamil on bronchial goblet cells of asthma
Source: Annual Congress 2010 - Models of airways disease
Year: 2010
Effect of oral procaterol on allergic inflammation examined by a murine asthmatic model
Source: Eur Respir J 2003; 22: Suppl. 45, 286s
Year: 2003
Assessment of
in vivo
5-lipoxygenase (5-LO) activity in nonatopic and atopic subjects with or without asthma: effects of treatment with the 5-LO inhibitor zileuton
Source: Eur Respir J 2003; 22: Suppl. 45, 101s
Year: 2003
Effect of 1,25(OH)
2
D
3
on the airway inflammation in asthmatic rat model
Source: Eur Respir J 2005; 26: Suppl. 49, 580s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept